Jasper Therapeutics, Inc. · NASDAQ:JSPR

Anders Hove reported a 6.40% stake in Jasper Therapeutics, Inc. (Schedule 13G)

Event Dec 1, 2025 · Filed Dec 2, 2025

Anders Hove reported a 6.40% stake in Jasper Therapeutics, Inc., 1,786,492 shares, as a passive investor on Dec 1, 2025. Filed Dec 2, 2025 (Schedule 13G).

Stake
6.40%
Shares
1,786,492
Intent
Passive
What changed
Crossed above 5%
Filed together
5 holders

The filing in full

HolderStakeShares
ACORN BIOVENTURES, L.P.2.70%750,326
ACORN CAPITAL ADVISORS GP, LLC2.70%750,326
ACORN BIOVENTURES 2, L.P.3.70%1,036,166
Acorn Capital Advisors GP 2, LLC3.70%1,036,166
Anders Hove6.40%1,786,492

Source

View original at SEC

Related